Lorglumide sodium salt
Lorglumide sodium salt (CR-1409) is a selective cholecystokinin (CCK) receptor antagonist. It is widely used in research to investigate CCK-mediated physiological processes, including pancreatic secretion and satiety, in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1021868-76-7
Product Name Alternative
Lorglumide sodium, CR-1409 sodium, CR-1409 sodium salt, CCK
Field of Research
Pharmacology & Drug Discovery
Purity
99.32% (May vary between batches)
Solubility
H2O:100 mg/mL (207.73 mM) ; DMSO:90 mg/mL (186.96 mM) ;10% DMSO+90% Corn Oil:3.3 mg/mL (6.86 mM)
Smiles
CCCCCN (C (C (NC (C1=CC (Cl) =C (Cl) C=C1) =O) CCC ([O-]) =O) =O) CCCCC.[Na+]
Molecular Formula
C22H31Cl2N2NaO4
Molecular Weight
481.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1063380-01 0.02 mg (E-Coli)
Recombinant Herminiimonas arsenicoxydans GTP cyclohydrolase folE2 (folE2)
Sign In for Pricing
View Details MBS1063380-02 0.02 mg (Yeast)
Recombinant Herminiimonas arsenicoxydans GTP cyclohydrolase folE2 (folE2)
Sign In for Pricing
View Details MBS1063380-03 0.1 mg (E-Coli)
Recombinant Herminiimonas arsenicoxydans GTP cyclohydrolase folE2 (folE2)
Sign In for Pricing
View Details